webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

m-PEG4-Boc

  CAS No.: 883554-11-8   Cat No.: BADC-01186   Purity: >98.0% 4.5  

m-PEG4-Boc is a cleavable 4 unit PEG ADC linker used in the synthesis of antibody-drug conjugates (ADCs). m-PEG4-Boc is also a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

m-PEG4-Boc

Structure of 883554-11-8

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C14H28O6
Molecular Weight
292.37
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Tert-Butyl 3-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}propionate; m-PEG4-t-butyl ester
IUPAC Name
tert-butyl 3-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]propanoate
Canonical SMILES
CC(C)(C)OC(=O)CCOCCOCCOCCOC
InChI
InChI=1S/C14H28O6/c1-14(2,3)20-13(15)5-6-17-9-10-19-12-11-18-8-7-16-4/h5-12H2,1-4H3
InChIKey
JUINYDFUOXIVCX-UHFFFAOYSA-N
Solubility
10 mm in DMSO
PSA
63.22000
Appearance
Solid
Shelf Life
0-4°C for short term (days to weeks), or -20°C for long term (months).
Shipping
Room temperature
Storage
Store at -20 °C, keep in dry and avoid sunlight.
Form
Solid

m-PEG4-Boc, a versatile polyethylene glycol derivative widely utilized in chemical synthesis, boasts diverse applications in pharmaceuticals and biotechnology. Here are four key applications of m-PEG4-Boc:

Drug Delivery Systems: The integration of m-PEG4-Boc in drug conjugate synthesis involves leveraging it as a hydrophilic linker to boost the solubility and stability of therapeutic agents. Through conjugation with this polymer, optimizations in pharmacokinetic profiles are achieved, resulting in prolonged circulation times and mitigated side effects.

Peptide and Protein Modification: In the realm of pegylating peptides and proteins, m-PEG4-Boc plays a pivotal role by attaching polyethylene glycol chains to these biomolecules. Pegylation with m-PEG4-Boc serves to augment molecular weight and modify pharmacodynamics, culminating in heightened bioavailability and reduced immunogenicity of therapeutic proteins.

Surface Functionalization: Within the domain of material science, m-PEG4-Boc is harnessed to modify surfaces, rendering them biocompatible and minimizing nonspecific binding. The presence of PEG chains on surfaces acts as a deterrent to protein adsorption and cell adhesion, critical for biomedical device and diagnostic instrument development. This functionalization is paramount in ensuring the efficacy and safety of implantable devices and sensors.

Bioconjugation: A mainstay in bioconjugation reactions, m-PEG4-Boc assumes a crucial role in linking biomolecules with diverse functional entities like fluorescent probes and therapeutic agents. The compound’s stability and ease of removal position it as a preferred choice for temporary protection during chemical synthesis processes. This application plays a pivotal role in crafting advanced pharmaceuticals for therapy and imaging, demanding precise spatial and functional control for optimal outcomes.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records: Methylcyclopropene-PEG4-NHS | Boc-Cystamine-Poc | Amino-PEG6-t-butyl ester | Azido-PEG1-Val-Cit-OH | Methyltetrazine-Maleimide | m-PEG4-Boc
Send Inquiry
Verification code
Inquiry Basket